 focused on antiplatelet therapy, antihypertensive therapy, and lipid-lowering therapy.
Thirty-day outcomes. Medical management was associated with a signiﬁcant decrease in strokes and combined stroke/death at 30 days compared with CEA (3
studies; RR, 0.26; 95% CI, 0.08-0.87 [Supplementary
Table I, online only], and RR, 0.24;